Clinical benefit among lenalidomide (LEN)-treated patients (pts) with RBC transfusion-dependent (RBC-TD) low-/int-1-risk myelodysplastic syndromes (MDS) without del(5q).

Garcia-Manero G., Almeida A. M., Fenaux P., Gattermann N., Giagounidis A., Goldberg S., ...More

Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, United States Of America, 3 - 07 June 2016, vol.34 identifier

  • Publication Type: Conference Paper / Summary Text
  • Volume: 34
  • Doi Number: 10.1200/jco.2016.34.15_suppl.7014
  • City: Illinois
  • Country: United States Of America
  • Hacettepe University Affiliated: No